SB414 6%

DRUG2 trials

Sponsors

Novan, Inc.

Conditions

Atopic DermatitisPsoriasis

Phase 1

A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis

CompletedNCT03431610

Novan, Inc.Atopic Dermatitis

Start: 2017-11-13End: 2018-05-11Updated: 2018-09-07

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

CompletedNCT03445013

Novan, Inc.Psoriasis

Start: 2017-10-13End: 2018-02-06Updated: 2018-03-27